Possible scenario
Regulation Accelerates
25% Chance
The financing lands in a policy environment already focused on chatbots, AI-designed viruses, and pathogen-design safeguards. Regulators may use the Red Queen Bio narrative to justify more formal screening, testing, and reporting standards for AI biology tools.
Secondary impacts
- Healthcare +0.4%
- Technology -0.1%
Tickers
- TWST+1.4%
- DNA+1.0%
- GOOG+0.1%
Portfolio impact
S&P 500+0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.